M Lebmeier: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Costs of Medication Nonadherence in Patients with Diabetes Mellitus: A Systematic Review and Critical Analysis of the Literature

Maribel Salas, Dyfrig Hughes, Alvaro Zuluaga, Kawitha Vardeva, Maximilian Lebmeier

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 112 KB

english, 2009

2

Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria

Bernhard Resch, Walter Gusenleitner, Mark J.C. Nuijten, Maximilian Lebmeier, Wolfgang Wittenberg

Journal:

Clinical Therapeutics

Year:

2008

Language:

english

File:

PDF, 1.68 MB

english, 2008

3

Regulatory associations between the metabolism of sulfur-containing amino acids and xanthan biosynthesis in Xanthomonas campestris pv. campestris B100

Schulte, Fabian, Leβmeier, Lennart, Voss, Julia, Ortseifen, Vera, Vorhölter, Frank-Jörg, Niehaus, Karsten

Journal:

FEMS Microbiology Letters

Year:

2019

Language:

english

File:

PDF, 1.60 MB

english, 2019

4

A novel valuation model for medical intervention development based on progressive dynamic changes that integrates Health Technology Assessment outcomes with early-stage innovation and indication-specific clinical success rates

Dando, Jonathan, Lebmeier, Maximilian

Journal:

Journal of Innovation and Entrepreneurship

Year:

2020

File:

PDF, 1.30 MB

2020

5

Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis

Patricia Guyot, Peter Taylor, Robin Christensen, Louisa Pericleous, Coralie Poncet, Maximilian Lebmeier, Pieter Drost, Gert Bergman

Journal:

Arthritis Research & Therapy

Year:

2011

Language:

english

File:

PDF, 345 KB

english, 2011

6

P.7.c.010 The cost effectiveness of aripiprazole for the treatment of adolescents with schizophrenia

L. Pericleous, E. Dudley, M. Lebmeier, A. Bentley, R. McAllister

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

7

PMC41 METHODOLOGICAL ISSUES IN THE LITERATURE ON COSTS OF NON-COMPLIANCE IN CHRONIC DISEASES

M Salas, A Zuluaga, D Hughes, W Cowell, M Lebmeier, K Vardeva, M Pisu, J Shinogle

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 96 KB

english, 2008

8

PSY11 EONOMIC EVALUATION OF ETANERCEPT COMPARED TO NO SYSTEMIC THERAPY IN THE MANAGEMENT OF LESS SEVERE CHRONIC PLAQUE PSORIASIS IN THE UK

JM Webber, AC Lloyd, M Lebmeier, P Conway, J Warburton

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 89 KB

english, 2008

9

PIH1 COST-EFFECTIVENESS MODEL OF PALIVIZUMAB IN THE NETHERLANDS

MJ Nuijten, M Lebmeier, P Daalderop, W Wittenberg

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 61 KB

english, 2005

10

PIN23 COST-EFFECTIVENESS MODEL OF PALIVIZUMAB IN THE UK

MJ Nuijten, M Lebmeier, W Wittenberg

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 64 KB

english, 2005

11

PMH52 COSTS OF NON-COMPLIANCE WITH ANTIPSYCHOTIC MEDICATIONS AMONG PATIENTS WITH SCHIZOPHRENIA

M Salas, A Zuluaga, D Hughes, M Lebmeier, K Vardeva, M Pisu, J Shinogle

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 68 KB

english, 2008

12

PSS6 COST-EFFECTIVENESS OF INTERMITTENT VS. CONTINUOUS ANTI-TNF ALPHA THERAPY IN PLAQUE PSORIASIS

AC Lloyd, JM Webber, M Lebmeier, P Conway, J Warburton

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 75 KB

english, 2008

13

PSS5 A COST COMPARISON OF ADALIMUMAB AND ETANERCEPT FOR THE TREATMENT OF CHRONIC PLAQUE PSORIASIS IN THE UNITED KINGDOM

M Lebmeier, P Conway, J Warburton

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 84 KB

english, 2009

14

PMS37 THE COST-EFFECTIVENESS OF ABATACEPT IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF PATIENT WITH ACTIVE RHEUMATOID ARTHRITIS AFTER AN INADEQUATE RESPONSE TO METHOTREXATE IN THE UNITED KINGDOM

M Lebmeier, L Pericleous, P Drost, P Dequen, M Ouwens, G Bergman, H Baig

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 68 KB

english, 2010

15

PMS71 INDIRECT TREATMENT COMPARISON TO COMPARE EFFICACY IN HEALTH ASSESSMENT QUESTIONNAIRE (HAQ) SCORE FOR BIOLOGIC AGENTS WITH METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ACTIVE DISEASE DESPITE METHOTREXATE THERAPY

M Lebmeier, L Pericleous, P Guyot, H Baig, R Christensen, G Bergman, PC Taylor, P Drost

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 75 KB

english, 2010

16

PMS75 MODELING OF RHEUMATOID ARTHRITIS: A METHODOLOGICAL APPROACH

MJ Taylor, C Righetti, P Conway, M Lebmeier

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 69 KB

english, 2010

17

PHP103 NICE GUIDANCE:AN ANALYSIS OF LEVELS OF RESTRICTION BY DISEASE AREA

OA Mesa, A Venus, M Lebmeier, M Davis, C Jones

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 68 KB

english, 2010

18

PCN68 AN ECONOMIC EVALUATION OF DASATINIB FOR THE TREATMENT OF IMATINIB REISTANT PATIENTS WITH CHRONIC MYELOGENOUS LEUKAEMIA

M. Taylor, L. Lewis, M. Lebmeier, Q. Wang

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 73 KB

english, 2011

19

PCN69 AN ECONOMIC EVALUATION OF DASATINIB FOR THE TREATMENT OF IMATINIB RESISTANT PATIENTS WITH ADVANCED PHASE CHRONIC MYELOGENOUS LEUKAEMIA

M. Taylor, L. Lewis, M. Lebmeier, Q. Wang

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 56 KB

english, 2011

20

PMS31 Cost-Effectiveness of Abatacept for the Treatment of Rheumatoid Arthritis (RA) After the Failure of a First TNF inhibitor in the United Kingdom

L. Pericleous, M. Lebmeier

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 74 KB

english, 2011

21

PMS79 Mixed Treatment Comparison of Biologic Agents in Patients with Rheumatoid Arthritis Who Have responded Inadequately to Methotrexate Therapy in the United Kingdom

M. Lebmeier, L. Pericleous, P.C. Taylor, R. Christensen, P. Drost, G. Bergman, I. Eijgelshoven, P. Guyot

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 60 KB

english, 2011

22

PSY38 A UK Based Cost-Effectiveness Analysis of Dasatinib (Sprycel) 100mg Daily Compared to Imatinib (Glivec) 400mg Daily in Newly Diagnosed Patients With Chronic Myeloid Leukemia (CML)

S. Mealing, M. Taylor, D. Scott, J. Clark, M. Mckenna, M. Lebmeier, I. Gilloteau, C. Davis

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 61 KB

english, 2012

23

PSY37 A UK Based Cost-Effectiveness Analysis of Dasatinib (Sprycel) 100mg Daily Compared to Imatinib (Glivec) 600/800mg Daily as Therapy for Imatinib Failing Chronic Myeloid Leukemia (CML)

M. Taylor, S. Mealing, D. Scott, J. Clark, M. McKenna, M. Lebmeier, C. Davis

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 61 KB

english, 2012

24

PCN80 Modelling the Cost-Effectiveness of Ipilimumab for Previously-Treated, Metastatic Melanoma

D. Lee, B. Winn, M. Lebmeier, A. Batty

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 61 KB

english, 2012

25

PMS80 Biologic Therapies for Rheumatoid Arthritis – Eligibility Criteria in the UK

M. Lebmeier, C. Righetti

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 60 KB

english, 2012

26

PUK22 Evaluating the Minimum Renal Allograft Survival Time Required for Transplantation to Remain Cost Saving in the UK

P. McEwan, M. Lebmeier

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 60 KB

english, 2012

27

CA4 A Comparison of Patient and General-Population Utility Values for Advanced Melanoma in Health Economic Modelling

A. Batty, B. Winn, M. Lebmeier, D. Rowen, D. Lee

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 59 KB

english, 2012

28

PHP2 THE MEDINET-PROJECT—A FEASIBILITY STUDY ON MEDICATION COMPLIANCE UNDER REAL LIFE CONDITIONS

R Sterz, M Lebmeier, U Simon

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 62 KB

english, 2005

29

PRS8 THE COST-EFFECTIVENESS OF PALIVIZUMAB IN AUSTRIA

B Resch, MJ Nuijten, M Lebmeier, W Wittenberg, W Gusenleitner

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

30

PMS17 THE ECONOMIC IMPLICATIONS OF ACHIEVING TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS

MJ Taylor, P Conway, M Lebmeier, R Batta

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 71 KB

english, 2008

31

PMS24 THE COST-EFFECTIVENESS OF SEQUENTIAL USE OF ANTI-TUMOR NECROSIS FACTOR AGENTS IN THE TREATMENT OF RHEUMATOID ARTHRITIS

MJ Taylor, P Conway, M Lebmeier, M Ganderton

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 74 KB

english, 2008

32

Assessing the Future Burden of Renal Replacement Therapy in the United Kingdom

McEwan, P., Ward, T., Righetti, C., Brenner, M., Lebmeier, M.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 59 KB

english, 2013

33

PMH31 THE COST-EFFECTIVENESS OF ARIPIPRAZOLE IN PATIENTS WITH BIPOLAR I DISORDER IN THE UK

Lebmeier, M, Dudley, E, Pericleous, L, Treur, M

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 70 KB

english, 2010

34

Contents

Lebmeier, M, Dudley, E, Pericleous, L, Treur, M

Journal:

Gastroenterology Clinics of North America

Year:

2009

Language:

english

File:

PDF, 39 KB

english, 2009

35

Modelling the Cost-Effectiveness of First-Line Biologics for Rheumatoid Arthritis in England and Wales

Righetti, C., Lebmeier, M., Pennington, B., Brereton, N.J.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 74 KB

english, 2013

36

PSS20 ECONOMIC EVALUATION OF BIOLOGIC THERAPIES FOR MODERATE TO SEVERE PSORIASIS: ETANERCEPT COMPARED TO ADALIMUMAB AND INFLIXIMAB

Webber, JM, Lloyd, AC, Lebmeier, M, Conway, P

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 80 KB

english, 2009

37

PSS8 Advanced Cutaneous Melanoma in the UK: A Systematic Review

Poku, E., Cooper, K., Wang, Q., Bapat, U., Lebmeier, M.

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 61 KB

english, 2011

38

Modelling the Cost-Effectiveness of First Line Biologics for Rheumatoid Arthritis in Ireland

Righetti, C., Lebmeier, M., Pennington, B., Brereton, N.J.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 55 KB

english, 2013

39

PDB39 Cost-Effectiveness of Saxagliptin Compared to Sitagliptin for the Treatment of Patients with Type 2 Diabetes Mellitus (T2DM)

Hutchings, A., Tolley, K., Achana, F., Brereton, N.J., Lebmeier, M., Mesa, O.A.

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 61 KB

english, 2011

40

Indirect Treatment Comparison of Abatacept with Methotrexate Versus Other Biologic Agents for Active Rheumatoid Arthritis Despite Methotrexate Therapy in the United Kingdom

GUYOT, P., TAYLOR, P. C., CHRISTENSEN, R., PERICLEOUS, L., DROST, P., EIJGELSHOVEN, I., BERGMAN, G., LEBMEIER, M.

Journal:

The Journal of Rheumatology

Year:

2012

Language:

english

File:

PDF, 513 KB

english, 2012

41

Cost effectiveness of palivizumab for RSV prevention in high-risk children in the Netherlands

Nuijten, Mark, Lebmeier, Maximilian, Wittenberg, Wolfgang

Journal:

Journal of Medical Economics

Year:

2009

Language:

english

File:

PDF, 359 KB

english, 2009

42

Cost Effectiveness of Palivizumab for Respiratory Syncytial Virus Prophylaxis in High-Risk Children

Nuijten, Mark J C, Wittenberg, Wolfgang, Lebmeier, Maximilian

Journal:

PharmacoEconomics

Year:

2007

Language:

english

File:

PDF, 287 KB

english, 2007

43

Cost effectiveness of palivizumab in children with congenital heart disease in Germany

Nuijten, Mark, Lebmeier, Maximilian, Wittenberg, Wolfgang

Journal:

Journal of Medical Economics

Year:

2009

Language:

english

File:

PDF, 283 KB

english, 2009

44

Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death

Hatswell, Anthony J, Pennington, Becky, Pericleous, Louisa, Rowen, Donna, Lebmeier, Maximilian, Lee, Dawn

Journal:

Health and Quality of Life Outcomes

Year:

2014

Language:

english

File:

PDF, 645 KB

english, 2014

45

Estimation of health care costs as a function of disease severity in people with psoriatic arthritis in the UK

Poole, C. D., Lebmeier, M., Ara, R., Rafia, R., Currie, C. J.

Journal:

Year:

2010

Language:

english

File:

PDF, 136 KB

english, 2010

46

Budget Impact Analysis of Low-Dose Methoxyflurane For The Treatment of Moderate-To-Severe Trauma Pain In Sweden

Lebmeier, M, Strait, LB, Hegarty, LV, Fielden, DJ

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 60 KB

english, 2017

47

Long-Term Survival of Patients with Advanced Melanoma Treated Second Line with Ipilimumab

Lee, D., Pericleous, L., Lebmeier, M., Winn, B., Batty, A., Nikoglou, T.

Journal:

Annals of Oncology

Year:

2012

File:

PDF, 59 KB

2012